Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoCroS trial of initial adalimumab versus standard step-up care in Crohn's disease
NL-OMON60732Phase 4Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Dec 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, sponsored by Maastricht University. Started Dec 2019; status: active, not recruiting.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON60732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60732.